Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Post by investisseur101on Feb 11, 2018 10:28am
177 Views
Post# 27540702

Near of 45 days

Near of 45 days2 Weeks before 45 days for complete the production and possibly we have a news about it. News january 8th WAK and NHC have worked collaboratively to complete the design of the vape pens to meet WAKs branding, budget, delivery and compliance requirements and objectives. NHC will supply all labour, equipment and services at its facilities to produce the hemp-based vaporizer pens in a ready-to-use form, completing the production of finished product within 45 days of order and initial payment. Read more at https://www.stockhouse.com/news/press-releases/2018/01/08/new-age-farm-s-wholly-owned-subsidiary-we-are-kured-llc-achieves-production#3zPEBbM6eiOc6sls.99
Bullboard Posts